Nextcureincis A Clinical Stage Biopharmaceutical Company Based In Beltsvillemarylandfounded In 2015The Company Is Focused On Discovering And Developing Innovative Immunomedicines To Treat Cancer And Other Diseasesthe Scientific Foundation Of Nextcure Is Rooted In The Research Of Drlieping Chen From Yale Universitywith Michael Richman Serving As The Initial Ceo Nextcure S Product Pipeline Includes Several Promising Candidatesthese Include Nc410A Fusion Protein That Blocks Immune Suppression In Cancernc525An Antibody Targeting Acute Myeloid Leukemianc181An Antibody For Alzheimerae S Diseasenc605Aimed At Chronic Bone Diseasesand Lncb74An Antibody Drug Conjugate Designed To Target Tumorsthe Company Aims To Provide These Treatments Through Healthcare Systems And Medical Professionalsfocusing On Advancing Therapies That Harness The Body S Immune System
No conferences found for this company.
| Company Name | Nextcure Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
